Latent Labs Unveils AI: On Feb 13, Latent Labs launched an AI platform targeting proteins and RNA for drug discovery, boasting 30% faster hit rates. Biotech insiders praised its potential for precision medicine, but skeptics demand hard data over promises. Read more
MedTech Jobs Slashed: FDA, CDC, and NIH cut 5,200 staff Feb 13—budget woes hit regulatory and research arms hard. MedTech Dive warns of approval delays stretching months; startups brace for the squeeze while big firms pivot. Read more
Pharma Stock Wobbles: Natco Pharma dropped 10% overnight Feb 13 after a bleak Q4 outlook—India’s generics titan stumbled on supply chain snags. Investors are jittery; could this ripple across the sector? Read more
Quick Take: Feb 13’s AI debut shines against job cuts and stock dips—innovation races, but stability’s on thin ice.
